Record Details

Dengue Vaccine Development at the Dengue virus serotypes

International Islamic Medical Journal

View Archive Info
 
 
Field Value
 
Title Dengue Vaccine Development at the Dengue virus serotypes
 
Creator Desi Irawati, Adinda
Salim, Hotimah Masdan
 
Subject Dengue hemorrhagic fever (DHF)
DENV
Vaccine
 
Description Dengue hemorrhagic fever (DHF) is a disease caused by dengue virus (DENV1-4) and is transmitted by the Aedes aegypti mosquito. However, in 2015, official data from the member countries, WHO reported more than 3.2 million cases, including 10,200 severe dengue cases and 1181 deaths. The protein encoded by the genome of dengue virus. Major structural and non structural proteins making up the genome of dengue. From genomic data several studies found that mechanism of vaccine that can use in dengue virus. Several vaccines was establish in the world for example Live attenuated Vaccine, Chimera Vaccine, Subunit Vaccine, DNA vaccines DENV, Activated DENV Vaccine  - Whole Virus Particles, Activated  DENV Vaccine - Recombinant Subunit DENV, and DENV Vaccine 5.
 
Publisher UNUSA Press
 
Date 2019-12-09
 
Type info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Peer-reviewed Article
 
Format application/pdf
 
Identifier https://journal2.unusa.ac.id/index.php/IIMJ/article/view/1360
10.33086/iimj.v1i1.1360
 
Source International Islamic Medical Journal; Vol. 1 No. 1 (2019): December; 9-15
Jurnal Medis Islam Internasional; Vol 1 No 1 (2019): December; 9-15
2716-2389
2716-2370
10.33086/iimj.v1i1
 
Language eng
 
Relation https://journal2.unusa.ac.id/index.php/IIMJ/article/view/1360/979